SNF-linked wound clinics saw fewer patients during pandemic but unchanged outcomes
By
Alicia Lasek
Nov 10, 2021
Investigators expected that wound outcomes would be adversely affected by pandemic disruptions. But data from hundreds of wound care clinics in the United States show otherwise.
Free LTC infection prevention tool from Yale aims to help nursing home staff save time
By
Alicia Lasek
Nov 09, 2021
A one-stop set of infection prevention resources is meant to make work a bit easier for direct care providers, administrators, managers and support staff, say the Yale School of Nursing and the New York...
At-home COVID-19 tests get a $70M boost as feds push to increase access
By
Alicia Lasek
Oct 27, 2021
The Biden Administration is streamlining the process to bring new tests to market among other moves designed to increase testing supplies and access.
FDA panel recommends second J&J coronavirus vaccine dose for adult recipients
By
Alicia Lasek
Oct 18, 2021
Independent experts have unanimously agreed that a full second dose of the drugmaker’s COVID-19 vaccine be offered to adults aged 18 years and older at least two months after receipt of the first...
Clinical briefs for Wednesday, Oct. 6
By
Alicia Lasek
Oct 06, 2021
Older adults less likely to recover smell, taste after COVID illness than their under-40 peers … CDC: Reduce citations with these antibiotic stewardship tools … Unvaccinated student nurses face disenrollment...
FDA may authorize half-dose booster of Moderna’s coronavirus vaccine
By
Alicia Lasek
Sep 30, 2021
A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.
Clinical briefs for Thursday, Sept. 23
By
Alicia Lasek
Sep 23, 2021
CDC advisers predict decline in coronavirus cases and deaths this fall … Antidiabetic treatment requires improvements to lower hypoglycemia risk in elders … Study pinpoints unmet clinical care needs...
First biosimilar approved by FDA to treat common eye degeneration in elders
By
Alicia Lasek
Sep 21, 2021
The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.
Clinical briefs for Monday, Sept. 20
By
Alicia Lasek
Sep 20, 2021
CNAs remain least vaccinated, requiring ‘large-scale’ solution … AARP says Florida leads nation in COVID deaths of nursing home residents, staff … Hardware-free virtual physical therapy system...
Clinical briefs for Thursday, Sept. 16
By
Alicia Lasek
Sep 16, 2021
U.S. to limit states’ access to COVID antibody treatments as demand rises … Aggressively reducing Alzheimer’s risk factors could mean 1.2 million fewer cases in 2050: experts … NIH launches nationwide...